VSEE (VSee Health) EBITDA: $-8.45 Mil (TTM As of Mar. 2026)


VSEE VSee Health Inc VSEE
8 GF Score
Price $0.11
! 5 Warning Signs
View Full Analysis

What is VSee Health EBITDA?

VSee Health VSEE +0.09% 8 EBITDA is $-8.45 Mil as of Mar. 2026. GuruFocus rates VSEE with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

VSee Health's EBITDA for the three months ended in Mar. 2026 was $-1.81 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-8.45 Mil.

During the past 3 years, the average EBITDA Growth Rate was -79.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 5 years, the highest 3-Year average EBITDA Growth Rate of VSee Health was -79.50% per year. The lowest was -79.50% per year. And the median was -79.50% per year.

VSee Health's EBITDA per Share for the three months ended in Mar. 2026 was $-0.04. Its EBITDA per share for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.26.

During the past 3 years, the average EBITDA per Share Growth Rate was -10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 5 years, the highest 3-Year average EBITDA per Share Growth Rate of VSee Health was -10.10% per year. The lowest was -10.10% per year. And the median was -10.10% per year.

VSee Health  (NAS:VSEE) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


VSee Health EBITDA Related Terms


VSee Health EBITDA Historical Data

* Premium members only.

The historical data trend for VSee Health's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

VSee Health EBITDA Chart

VSee Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA
0.39 -1.59 -1.70 -57.76 -9.18

VSee Health Quarterly Data
Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.55 -1.70 1.14 -6.07 -1.81

VSEE vs MGRX, HCTI, MNDR: EBITDA Comparison

For the Health Information Services subindustry, VSee Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VSee Health EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, VSee Health's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where VSee Health's EV-to-EBITDA falls into.


VSEE
8GF Score
VSee Health Inc VSEE
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

VSee Health's EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

VSee Health's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2025, VSee Health's EBITDA was $-9.18 Mil.

VSee Health's EBITDA for the quarter that ended in Mar. 2026 is calculated as

VSee Health's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Mar. 2026, VSee Health's EBITDA was $-1.81 Mil.

EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.45 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of $-8.45 Mil mean?
VSee Health (VSEE) has a EBITDA of $-8.45 Mil as of Mar. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on VSee Health.
Is VSee Health's EBITDA too high?
VSee Health's current EBITDA is $-8.45 Mil. Overall, VSee Health has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does VSee Health's EBITDA compare to MGRX and HCTI?
VSee Health's EBITDA of $-8.45 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Healthcare Providers & Services company?
A good EBITDA depends on the Healthcare Providers & Services industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on VSee Health. VSee Health's current EBITDA is $-8.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VSee Health stock overvalued right now?
VSee Health (VSEE) has a current EBITDA of $-8.45 Mil. The current EBITDA is $-8.45 Mil. VSee Health's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For VSee Health (VSEE), the current EBITDA is $-8.45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

VSee Health Business Description

Address 980 N Federal Highway, Suite 304, Boca Raton, FL, USA, 33432
VSee Health Inc is a telehealth software platform offer a comprehensive telehealth platform for U.S. hospitals and enterprises. Through VSee Lab, the company offer a set of telehealth software building blocks, data connectors, and workflow templates that can be rapidly configured into the clients workflows. Companies offerings allow clinicians without programming experience to configure building blocks into their existing workflow without requiring programmers. These set of building blocks can connect to electronic medical record systems such as EPIC and Cerner via HL7, FHIR, and sFTP. The entire telehealth platform sits on a scalable server architecture and is HIPAA compliant and SOC2 externally audited.
8GF Score

Get the complete analysis for VSEE

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price